Patient‐Reported Outcomes Selected by Paediatric Patients With Atopic Dermatitis in the Aiming High in Eczema/Atopic Dermatitis Approach
JEADV Clinical Practice · 2026-06 · 5 (2) · 610-614
DOI: 10.1002/jvc2.70246 ↗Kurz gefasst
Fachartikel in der Zeitschrift JEADV Clinical Practice, online erschienen am 30.11.2025. Verfasst von Yuji Fujita und 10 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
The Aiming High in Eczema/Atopic Dermatitis (AHEAD) approach, which combines treat‐to‐target principles and shared decision‐making, was proposed by international expert dermatologists.
Objectives
To understand which atopic dermatitis (AD) features children with AD and their caregivers, who visited paediatric departments, consider important, we investigated which AD features patients/caregivers would choose as patient‐reported outcomes.
Methods
The subjects were paediatric patients aged 0–18 years with AD. The patients and caregivers were asked to select one to three troublesome AD features as patient‐reported outcomes based on the AHEAD approach and rank them. For patients aged < 6 years, only their caregivers responded, whereas in the case of those aged ≥ 6 years, both the patients and their caregivers responded.
Results
Overall, 290 patients were included, of whom 113 and 177 were aged < 6 and 6–18 years. The troublesome AD feature most commonly selected by caregivers of patients aged 0–5 years was itch (96/113, 85.0%), followed by skin appearance/condition (79/113, 69.9%) and sleep disturbance (43/113, 38.1%). The same features were most commonly selected by patients aged ≥ 6 years who answered their own questions, and the corresponding numbers were as follows: itch, 158/177 (89.3%); skin appearance/condition, 109/177 (61.6%); and sleep disturbance, 45/177 (25.4%). Furthermore, these AD features were compared in the 6–12 and 13–18 years groups ( n = 102 and 75, respectively). Skin appearance/condition was more commonly selected by the 13–18 years group compared with the 6–12 years group, and the intergroup difference was significant (13–18 years group: 86.7% vs. 6–12 years group: 44/102, 43.1%; p < 0.01). However, intergroup differences in other AD features were not significant.
Conclusions
AD treatment aimed at true remission based on the AHEAD approach is desirable for children and their caregivers.
Zitieren
APA
Fujita, Y., Kajitani, S., Miyamoto, M., Ando, Y., Kato, M., Fukuda, H., Yamada, Y., Kitahara, N., Fukuda, N., Shiraishi, H., & Yoshihara, S. (2026). Patient‐Reported Outcomes Selected by Paediatric Patients With Atopic Dermatitis in the Aiming High in Eczema/Atopic Dermatitis Approach. JEADV Clinical Practice, 5(2), 610-614. https://doi.org/10.1002/jvc2.70246
Vancouver
Fujita Y, Kajitani S, Miyamoto M, Ando Y, Kato M, Fukuda H, et al. Patient‐Reported Outcomes Selected by Paediatric Patients With Atopic Dermatitis in the Aiming High in Eczema/Atopic Dermatitis Approach. JEADV Clinical Practice. 2026;5(2):610-614. doi:10.1002/jvc2.70246
BibTeX
@article{Fujita2026,
author = {Fujita, Yuji and Kajitani, Sayuri and Miyamoto, Manabu and Ando, Yusuke and Kato, Masaya and Fukuda, Hironobu and Yamada, Yumi and Kitahara, Nozomu and Fukuda, Norimasa and Shiraishi, Hideaki and Yoshihara, Shigemi},
title = {Patient‐Reported Outcomes Selected by Paediatric Patients With Atopic Dermatitis in the Aiming High in Eczema/Atopic Dermatitis Approach},
journal = {JEADV Clinical Practice},
year = {2026},
volume = {5},
number = {2},
pages = {610--614},
doi = {10.1002/jvc2.70246}
}
EUVIMED